Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Primary Brain Cancer
2.
Drug Delivery Global Industry Guide
3.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
4.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
5.
BioNewsCast Press Release Distribution Service
6.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
7.
Cell Therapy - Technologies, Markets and Companies
8.
Cytogenetics - technologies, markets and companies
9.
Molecular Diagnostics Markets
10.
The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
The Future of Monoclonal Antibody Therapeutics - Innovation in antibody engineering, key growth strategies and forecasts to 2011
The market for therapeutic monoclonal antibodies (mAbs) is one of the most dynamic sectors within the pharmaceutical industry; next generation antibodies are forecast to drive the market towards the $30 billion mark by 2011 due to a high level of innovation in early-stage discovery and several potential nichebusters set to launch in the next 5 years. The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011 is a unique report that combines up-to-date analysis of the current antibodies market with detailed insights into therapeutic, technology, discovery and drug delivery trends set to shape the market in the next 5 years and beyond. Gain access to the most comprehensive data on the antibody market and take advantage of exclusive insights into research trends from early stage discovery to marketed drugs.
This report provides:
Up-to-date global sales data with a comprehensive examination of key brands and detailed analysis of market dynamics, enabling you to analyze the competition and identify the critical success factors behind todays leading brands.
Forecasts of current marketed antibodies and all pipeline drugs predicted to launch before 2011, with a detailed examination of the factors influencing future sales, ensuring that you implement strategies to optimize future revenue streams.
The latest innovation trends in antibody discovery platforms, antibody engineering and non-invasive drug delivery, to guarantee that you stay up-to-date with recent developments and identify lucrative areas of investment.
In-depth company profiles of the leading drug developers and technology innovators in the market including Genentech, MedImmune, XOMA and Crucell, providing a comprehensive view of your competitors.
Therapy area analysis of forecasted antibody sales, including inflammatory disorders, oncology and infectious disease, allowing you to identify areas poised for growth.
Alliance and M&A information from MedTRACK, including key acquisitions made by AstraZeneca, Novartis and Amgen, enabling you to understand the changing antibody market.
Gain access to the most comprehensive data on the antibody market and take advantage of exclusive insights into research trends from early stage discovery to marketed drugs.
July 2006, PDF
Table of Contents
Full Table of Contents (PDF)
Price: $2,875.00 / GBP1,437.50
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.